Status:
TERMINATED
First choIce Antidepressants: General Practitioner's Treatment Approach in the Czech Republic
Lead Sponsor:
Angelini Pharma Česká republika s.r.o.
Collaborating Sponsors:
Institut biostatistiky a analýz, s.r.o. (IBA)
MINDPAX, s.r.o.
Conditions:
Major Depressive Disorder Co-Occurrent With Anxiety
Adult Patients
Eligibility:
All Genders
18+ years
Brief Summary
According to the local guidelines (Recommendation for General Practitioners), the first choice Anti-Depressant (AD) in Major Depressive Disorder (MDD) in primary care should be selective serotonin reu...
Detailed Description
Research question: What are the common clinical practices adopted by general practitioner - diagnostic process and treatment of choice (pharmacologic with details of first choice antidepressant) in p...
Eligibility Criteria
Inclusion
- Signing of the Inform Consent Form (Personal Data Protection Consent included)
- Adults male and female newly diagnosed with depression in care of the general practitioner
Exclusion
- Patients previously treated with depression or patients treated by a psychiatrist
- Pregnancy and breast-feeding
- Acute myocardial infarction
- Significant risk of suicide
- Concomitant antidepressant medication
Key Trial Info
Start Date :
October 15 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 30 2023
Estimated Enrollment :
28 Patients enrolled
Trial Details
Trial ID
NCT05291897
Start Date
October 15 2021
End Date
June 30 2023
Last Update
July 18 2023
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
MUDr. František Rolinek, s.r.o.
Brno, Czechia, 602 00
2
Artemisia všeobecné lékařství, s.r.o.
Brno, Czechia
3
MEDIGATE Care s.r.o.
Hradec Králové, Czechia, 50009
4
AAAmbulance, s.r.o.
Litoměřice, Czechia, 14000